Strong evidence that GNB1L is associated with schizophrenia

Williams, Nigel Melville ORCID: https://orcid.org/0000-0003-1177-6931, Glaser, Beate, Norton, Nadine ORCID: https://orcid.org/0000-0002-3848-4288, Williams, Hywel John ORCID: https://orcid.org/0000-0001-7758-0312, Pierce, Timothy, Escott-Price, Valentina ORCID: https://orcid.org/0000-0003-1784-5483, Monks, Stephen, Del Favero, Jurgen, Goossens, Dirk, Rujescu, Dan, Kirov, George ORCID: https://orcid.org/0000-0002-3427-3950, Craddock, Nicholas John ORCID: https://orcid.org/0000-0003-2171-0610, Murphy, Kieran Christopher, O'Donovan, Michael Conlon ORCID: https://orcid.org/0000-0001-7073-2379 and Owen, Michael John ORCID: https://orcid.org/0000-0003-4798-0862 2008. Strong evidence that GNB1L is associated with schizophrenia. Human Molecular Genetics 17 (4) , pp. 555-566. 10.1093/hmg/ddm330

Full text not available from this repository.

Abstract

Evidence that a gene or genes on chromosome 22 is involved in susceptibility to schizophrenia comes from two sources: the increased incidence of schizophrenia in individuals with 22q11 deletion syndrome (22q11DS), and genetic linkage studies. In mice, hemizygous deletion of either Tbx1 or Gnb1l can cause deficits in pre-pulse inhibition, a sensory motor gating defect which is associated with schizophrenia. We tested the hypothesis that variation at this locus confers risk of schizophrenia and related disorders in a series of case-control association studies. First we found evidence for a male-specific genotypic association (p=0.00017) TBX1/GNB1L in 662 schizophrenia cases and 1416 controls from the UK. Moreover, we replicated this finding in two independent case control samples (additional 746 cases and 1330 controls) (meta analysis p=1.8x10–5) and also observed significant evidence for genotypic association in an independent sample of 480 schizophrenia parent-proband trios from Bulgaria with markers at this locus, which was again strongest in the male probands (p=0.004). Genotyping the most significant SNPs in a sample of 83 subjects with 22q11DS with and without psychosis again revealed a significant allelic association with psychosis in males with 22q11DS (p=0.01). Finally, using allele specific expression analysis we have shown that the markers associated with psychosis are also correlated with alterations in GNB1L expression, raising the hypothesis that the risk to develop psychosis at this locus could be mediated in a dose sensitive manner via gene expression. However, other explanations are possible, and further analyses will be required to clarify the correct functional mechanism.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) Neuroscience and Mental Health Research Institute (NMHRI)
Publisher:	Oxford University Press
ISSN:	0964-6906
Last Modified:	01 Dec 2022 09:48
URI:	https://orca.cardiff.ac.uk/id/eprint/608

Citation Data

Cited 53 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item